
1.33 Delayed Data As of Sep 21 | ![]() Today’s Change | 0.25 Today|||52-Week Range 1.40 | +150.00% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.40 and a low estimate of 1.11. The median estimate represents a -5.28% decrease from the last price of 1.33.
The current consensus among 4 polled investment analysts is to Hold stock in Zynerba Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.